XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Research and Development Activity (Details) - INKmune License Agreement [Member] - Patents [Member] - Immune Ventures Llc [Member]
6 Months Ended
Jun. 30, 2020
USD ($)
Each Phase I initiation [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments $ 25,000
Each Phase II initiation [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 250,000
Each Phase III initiation [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 350,000
Each NDA/EMA filing [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 1,000,000
Each NDA/EMA awarded [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments $ 9,000,000